0000904454-19-000115.txt : 20190129 0000904454-19-000115.hdr.sgml : 20190129 20190129204734 ACCESSION NUMBER: 0000904454-19-000115 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190125 FILED AS OF DATE: 20190129 DATE AS OF CHANGE: 20190129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: van Deventer Sander CENTRAL INDEX KEY: 0001543084 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36294 FILM NUMBER: 19550140 MAIL ADDRESS: STREET 1: POSTBUS 5187 CITY: NAARDEN STATE: P7 ZIP: 1410 AD ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: uniQure N.V. CENTRAL INDEX KEY: 0001590560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP BUSINESS PHONE: 1-339-970-7000 MAIL ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP FORMER COMPANY: FORMER CONFORMED NAME: uniQure B.V. DATE OF NAME CHANGE: 20131030 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-01-25 0001590560 uniQure N.V. QURE 0001543084 van Deventer Sander C/O UNIQURE N.V. PAASHEUVELWEG 25A AMSTERDAM P7 1105BP NETHERLANDS 0 1 0 0 Chief Scientific Officer Ordinary Shares 2019-01-25 4 A 0 5589 0 A 30658 I See footnote Ordinary Shares 2019-01-25 4 A 0 10913 0 A 41571 I See footnote Stock Option (Right to Buy) 31.71 2019-01-25 4 A 0 18325 0 A 2029-01-25 Ordinary Shares 18325 18325 D Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates. Shares held by SJH van Deventer C.V., an entity affiliated with Forbion Capital Partners ("FCP"), or required to be transferred to FCP under the Reporting Person's employment agreement with FCP. The Reporting Person has a partial beneficial interest in such shares as a managing partner of FCP, however he disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Represents performance-based restricted share units ("PRSUs") granted on January 26, 2018 to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated, which vested on January 25, 2019. Each PRSU represents the contingent right to receive one Ordinary Share. The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. /s/ Christian Klemt, Attorney-in-Fact 2019-01-29